-

Medical Engineered Materials Market by Type, Application and Region - Global Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Engineered Materials Market by Type (Medical Plastics, Medical Foams, Medical Films, Medical Elastomers, Medical Adhesives), Application (Medical Device, Disposables, Medical Wearables, Advanced Wound Care), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%.

This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations for minimally invasive surgical procedures is increasing demand for medical engineered materials globally. Advancements in the designing of medical electronic components is also among the major drivers of the medical engineered materials consumption.

Medical Plastics accounted for the largest share in total medical engineered materials market

Medical plastics is the largest type among other medical engineered materials used in the manufacture of medical devices and disposables. Medical plastics can be classified as plastics used to manufacture medical disposables, medical instruments & tools, and drug delivery devices. Growing healthcare infrastructure in emerging economies and increasing instances of chronic diseases are expected to drive the medical devices market, which, in turn, is likely to propel the demand for medical plastics.

Medical disposables accounted for the largest market share

The medical disposables segment accounted for the largest share in the overall market in 2019. Medical disposables can be defined as products, which are designed for single-use applications. Increased incidences of chronic diseases, changing lifestyle of the middle-income group, demand for better healthcare facilities, and an increase in the ageing population are the major drivers for the market

APAC is the largest and fastest growing medical engineered materials market globally

APAC was the largest market for medical engineered materials in 2019. Growth in APAC is primarily attributed to the fast-paced expansion of the economies, such as China, India, Indonesia, Thailand, Australia, and Malaysia. The region has become an attractive location for pharmaceutical drug production and medical equipment manufacturing companies. The major drivers for the medical devices sector in APAC are the change in reforms regarding value-based care in existing systems, ecosystem partnership across the value-chain, increasing R&D, and digitalization of the healthcare system.

Market Dynamics

Drivers

  • Rising Geriatric Population Demands Advanced Medical Technologies and Devices
  • Growing Healthcare Investments in Emerging Economies
  • Shift Toward Minimally Invasive Surgical Procedures

Restraints

  • Time Consuming Regulatory Procedures

Opportunities

  • R&D to Create Advanced Materials
  • Development of Patient-Specific Equipment Using 3D Printing

Challenges

  • Medical Waste Management Concerns

Companies Mentioned

  • 3M
  • Arkema
  • B.Braun
  • BASF
  • Baxter International
  • Celanese Corporation
  • Covestro
  • DSM
  • Dupont
  • Eastman Chemical Company
  • Ensinger
  • Ethicon
  • Evonik
  • Henkel
  • Huntsman Corporation
  • Momentive Performance Materials Inc.
  • Nitto Denko
  • Recticel
  • RTP Company
  • Sabic
  • Sekisui Chemical
  • Solvay
  • Strategic Choices Made
  • Teknor Apex
  • Trelleborg Ab
  • Trinseo

For more information about this report visit https://www.researchandmarkets.com/r/1jbzqf

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom